Discharging patients on an oral anticoagulation (OAC) or a reduced antithrombotic regimen, such as single antiplatelet therapy (SAPT) following Amulet Left Atrial Appendage Occlusion (LAAO) implantation, may be a viable alternative to the current dual antiplatelet therapy (DAPT) regimen, new data suggests.